"Cholinergic Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.
| Descriptor ID |
D018680
|
| MeSH Number(s) |
D27.505.519.625.120.200 D27.505.696.577.120.200
|
| Concept/Terms |
Cholinergic Antagonists- Cholinergic Antagonists
- Antagonists, Cholinergic
- Cholinergic Antagonist
- Antagonist, Cholinergic
- Cholinergic-Blocking Agents
- Agents, Cholinergic-Blocking
- Cholinergic Blocking Agents
- Cholinolytics
- Acetylcholine Antagonists
- Antagonists, Acetylcholine
- Cholinergic Receptor Antagonists
- Antagonists, Cholinergic Receptor
- Receptor Antagonists, Cholinergic
Anticholinergic Agents- Anticholinergic Agents
- Agents, Anticholinergic
- Anticholinergics
- Anti-Cholinergics
- Anti Cholinergics
|
Below are MeSH descriptors whose meaning is more general than "Cholinergic Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Cholinergic Antagonists".
This graph shows the total number of publications written about "Cholinergic Antagonists" by people in this website by year, and whether "Cholinergic Antagonists" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 4 | 5 |
| 1998 | 1 | 2 | 3 |
| 1999 | 1 | 3 | 4 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 4 | 5 |
| 2002 | 2 | 2 | 4 |
| 2003 | 1 | 0 | 1 |
| 2004 | 3 | 3 | 6 |
| 2005 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 6 | 8 |
| 2008 | 2 | 0 | 2 |
| 2009 | 3 | 1 | 4 |
| 2010 | 1 | 5 | 6 |
| 2011 | 2 | 6 | 8 |
| 2012 | 2 | 3 | 5 |
| 2013 | 6 | 4 | 10 |
| 2014 | 4 | 0 | 4 |
| 2015 | 4 | 1 | 5 |
| 2016 | 4 | 2 | 6 |
| 2017 | 4 | 0 | 4 |
| 2018 | 4 | 1 | 5 |
| 2019 | 5 | 4 | 9 |
| 2020 | 1 | 1 | 2 |
| 2021 | 6 | 6 | 12 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 6 | 6 |
| 2024 | 1 | 4 | 5 |
Below are the most recent publications written about "Cholinergic Antagonists" by people in Profiles.
-
Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States. Urology. 2024 Sep; 191:49-56.
-
The Drug Burden Index Is Associated With Measures of Cognitive Function Among Older Adults in the Health, Aging, and Body Composition Study. J Gerontol A Biol Sci Med Sci. 2024 Jul 01; 79(7).
-
Fragility of overactive bladder medication clinical trials: A systematic review. Neurourol Urodyn. 2024 Sep; 43(7):1523-1533.
-
Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases. Dig Dis Sci. 2024 Mar; 69(3):766-774.
-
Use of different anticholinergic scales and their correlation with anticholinergic symptom burden in a cohort of people living with HIV. J Antimicrob Chemother. 2024 01 03; 79(1):66-77.
-
Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine (Baltimore). 2023 Jul 01; 102(S1):e32377.
-
Effects of Anticholinergic Burden on Verbal Memory Performance in First-Episode Psychosis. Can J Psychiatry. 2023 12; 68(12):894-903.
-
Impact of Anticholinergic Medications on Speech Perception Performance after Cochlear Implantation. Otol Neurotol. 2023 07 01; 44(6):e364-e368.
-
TReating Incontinence for Underlying Mental and Physical Health (TRIUMPH): a study protocol for a multicenter, double-blinded, randomized, 3-arm trial to evaluate the multisystem effects of pharmacologic treatment strategies for urgency-predominant urinary incontinence in ambulatory older women. Trials. 2023 Apr 21; 24(1):287.
-
Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden. Am J Psychiatry. 2023 07 01; 180(7):519-523.